Testing effectiveness (Phase 2)Study completedNCT05025332
What this trial is testing
An Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001)
Who this might be right for
Pitt Hopkins Syndrome
Neuren Pharmaceuticals Limited 28
Showing 8 of 8 results